
Sarah Lakadawala, DNP, GLP-1 Microdosing for Autoimmune Inflammation & Fatigue
Can GLP-1 medications help people with autoimmune conditions feel better, even at very low doses? In this episode of the Get Healthy Tampa Bay Podcast, Dr. Kerry Reller welcomes one of CFMA's own, Sarah Lakadawala, DNP, a nurse practitioner who recently earned her Doctor of Nursing Practice from USF. Her doctoral project looked at low-dose semaglutide in patients living with autoimmune disease, and the results focused not just on weight, but on quality of life.
Meet Sarah Lakadawala, DNP
Sarah was born and raised in Texas and graduated from the University of Texas at Austin. She started her nursing career as an ICU nurse, then moved into urgent care and family medicine. A Doctor of Nursing Practice (DNP) adds about a year of research-focused training beyond a master's degree, and each student completes a project addressing a real need in a clinical or community setting. Sarah found she loved digging into the latest research, which led her to this project.
Why Autoimmune Disease and GLP-1s?
In an autoimmune disease, the immune system mistakenly attacks the body's own tissues, keeping the body in a constant state of inflammation. Sarah noticed that many CFMA patients with conditions such as rheumatoid arthritis, lupus, Hashimoto's and Graves' disease, as well as related inflammatory conditions like PCOS, struggled with fatigue, pain and weight changes, and were often on many medications, including long-term steroids. Because obesity also drives inflammation, and GLP-1 medications (the class that includes Ozempic, Wegovy, Mounjaro and Zepbound) appear to lower inflammatory markers, she wanted to see whether low-dose treatment could help.
How the Project Worked
22 patients with an autoimmune diagnosis from another provider took part over a three-month intervention period. Underweight patients were excluded.
Low starting dose: Everyone started on 0.125 mg of compounded semaglutide, half the usual 0.25 mg starting dose, sometimes called "microdosing." Some later moved to 0.25 mg, and no one went higher.
Weight loss was not the main goal: Many patients simply wanted to feel better.
Support included: Weekly check-ins and counseling on an anti-inflammatory diet.
What was measured: Baseline safety labs, CRP (a general inflammation marker) and two standardized quality-of-life surveys, the Fatigue Severity Scale and PROMIS-29, before and after.
This was an observational quality improvement project, not a randomized controlled trial, and it has been submitted for publication.
What She Found
Fatigue improved significantly: Fatigue Severity Scale scores showed a statistically significant improvement.
Mood and sleep improved: PROMIS-29 showed statistically significant improvements in anxiety, depression and sleep. Physical function and fatigue on that survey improved, though not significantly.
CRP did not change significantly: Patients were on different treatments, and some already had well-controlled CRP from biologics. Sarah would focus on a single autoimmune condition in a future study.
Some reduced other medications: Several patients lowered their thyroid medication, biologic dose or steroid use. One patient who typically has three to four flares a year had her first flare only after a long stretch.
Key Takeaways
GLP-1s may offer benefits beyond weight loss, including possible effects on inflammation and quality of life, though more research is needed.
Lower doses may be enough for some people: Several patients chose to stay on 0.125 mg because they liked how they felt.
Fatigue can have many causes: If you feel tired on a GLP-1, look at whether you are eating enough. One patient with rheumatoid arthritis felt better after switching from semaglutide to a low dose of tirzepatide.
Body composition would add insight: Measuring visceral fat, which drives inflammation, and muscle mass could help explain results in future studies.
Long-term data is still growing: GLP-1s have been around for well over a decade, but not as long as many older medications.
One Anti-Inflammatory Habit to Start
Sarah's advice: pick one change in your diet and do it consistently every day. It does not have to be big or perfect, just consistent.
Conclusion
This small study adds to growing interest in how GLP-1 medications might help people living with chronic inflammatory and autoimmune conditions feel more like themselves. If you live with an autoimmune condition and struggle with fatigue, pain or weight, talk with your provider about whether this approach could be right for you. To make an appointment at Clearwater Family Medicine and Allergy, call (727) 446-1097 or visit cfma.health.
About Our Guest
Sarah Lakadawala is a nurse practitioner at CFMA. She earned her Doctor of Nursing Practice degree from the University of South Florida, where her work focused on GLP-1 therapy and autoimmune conditions.
Listen to the full episode on the Get Healthy Tampa Bay Podcast: Sarah Lakadawala, DNP, GLP-1 Microdosing for Autoimmune Inflammation & Fatigue
Listen and Learn More
Watch the full episode above or listen to the Get Healthy Tampa Bay Podcast on your favorite podcast app. To schedule a visit with Dr. Kerry Reller at Clearwater Family Medicine and Allergy in Clearwater or Palm Harbor, call (727) 446-1097.
